Curaleaf Holdings, Inc (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, has completed the buyout of the remaining 45% stake not previously owned in Four 20 Pharma GmbH, a fully EU-GMP and GDP licensed German producer and distributor of medical cannabis. Four 20 Pharma is recognized for its high-quality cultivation, pharmaceutical-grade processing, and comprehensive distribution network across Germany and select European markets, serving nursing homes, pharmacies, and research institutions.
Read the full article: Curaleaf Completes Buyout of Remaining Stake in Germany’s Four 20 Pharma //
Source: https://www.prnewswire.com/news-releases/curaleaf-completes-buyout-of-remaining-stake-in-germanys-four-20-pharma-302759403.html